Pluxee Stock Midday: Rebound Despite UBS Pressure
Pluxee shares are up 2.72% this Wednesday, January 28, at midday, reaching 11.32 euros, after experiencing a significant downgrade by UBS on January 23. The Swiss bank downgraded its recommendation from neutral to sell while reducing its price target to 10 euros, amid a year-long drop of over 50%. The employee benefits solutions specialist is dealing with ongoing uncertainties surrounding Brazilian regulations, its primary market.
UBS's Strong Move on January 23
The Swiss bank UBS made a significant move on January 23 by downgrading its recommendation on Pluxee from neutral to sell, setting a new price target of 10 euros. This decision stems from the firm's assessment that regulatory uncertainty in Brazil remains too high for the next six to twelve months, leading it to believe that adopting a positive outlook equates to betting on favorable regulatory developments. This latest revision is part of a series of downward adjustments, after Alphavalue reduced its target from 29.40 euros to 21 euros in mid-January, while Morgan Stanley cut it from 23 to 21 euros in December. The Brazilian government has introduced changes to the Worker's Food Program, including setting a cap on merchant commission rates, reducing reimbursement periods, and implementing interoperability of vouchers, with significant uncertainties remaining about the scope and timing of these measures. Facing this situation, Pluxee posted a revenue of 308 million euros in the first quarter of fiscal 2026, with organic growth of 9%, while confirming its revised annual targets after having to lower its ambitions in November, now anticipating stable total revenue against previously expected high growth. Management expects that the Brazilian measures will continue to impact results in the first half of fiscal 2027, before returning to a sustainable growth trajectory starting in the second half of 2027.
Technical Analysis Shows Ongoing Weakness
The technical chart reveals a persistent weakness in the stock. The current price of 11.32 euros is significantly below the 50-day moving average of 12.85 euros and far from the 200-day average of 16.54 euros, confirming a structural weakening across all time horizons. The RSI indicator is at 29, signaling an oversold zone without reaching the extreme level observed in mid-January, suggesting a depletion of selling pressures that could fuel occasional technical rebounds like the one seen today. The immediate support threshold is set at 10.90 euros, relatively close to the current level, while resistance remains fixed at 13.41 euros, posing a major obstacle in case of continued rebound. The one-month volatility reaches 13.37, reflecting the magnitude of fluctuations experienced by the stock in an environment marked by investor anxiety over regulatory challenges. With a three-month performance down by 31.56% and an annual decline of 49.69%, the stock's trajectory remains heavily penalized by successive revisions of forecasts and the prevailing pessimism of financial intermediaries regarding short-term prospects.
